640.F China Resources Pharmaceutical Group Limited

Healthcare Pharmaceuticals Frankfurt Exchange
0.5050 EUR
Close of Nov 12, 2026
0.4414 0.6725
Market cap
EUR 3.17B
P/E
6.3x
P/B
0.46x
ROE
7.9%
Dividend yield
5.21%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 640.F undervalued?

Graham number
Price0.5050
Graham value1.41
Discount64.1%

640.F trades 64.1% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

China Resources Pharmaceutical Group Limited fundamental analysis

No fundamental analysis for China Resources Pharmaceutical Group Limited yet.

China Resources Pharmaceutical Group Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About China Resources Pharmaceutical Group Limited

China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products…

Full company profile